Nonpharmological interventions are becoming an increasingly essential part of pain management, especially in pediatric practice. Not only do findings suggest that interventions such as distraction, positioning and cold application may help to reduce patients' pain perception, but nurses can also implement these methods independently, enhancing their ability to care for children and their families. In addition, nonpharmacological methods are relatively inexpensive ([@b1-prm-20-e28]). To reduce the perception of pain in children, several prevention strategies have been proposed including sedative premedication ([@b2-prm-20-e28]), behavioural preparation programs, music therapy ([@b3-prm-20-e28]), animated cartoon visualization ([@b4-prm-20-e28]--[@b7-prm-20-e28]), hypnosis ([@b8-prm-20-e28]) and acupuncture ([@b9-prm-20-e28]). Some of these interventions, such as cartoon visualization and musical distraction, are used fairly frequently, whereas others -- including hypnosis and acupuncture -- are used less frequently because of undesirable side effects, time constraints or increased health care costs ([@b10-prm-20-e28],[@b11-prm-20-e28]).

Using animals in health care as a therapeutic healing modality has recently gained popularity ([@b12-prm-20-e28]). As the name suggests, animal-assisted therapy (AAT) is a goal-directed intervention in which an animal that meets specific criteria is an integral part of a treatment process. AAT is directed and/or delivered by a health/human service professional with specialized expertise in animals and health care, and is designed to promote improvements in human physical, social, emotional and/or cognitive functioning. AAT is acknowledged and used across the health care continuum (in outpatient care and acute care \[[@b13-prm-20-e28]\] and extended care facilities \[[@b14-prm-20-e28]\]) as an adjunctive therapy for use by nurses and across all patient populations, from pediatrics ([@b15-prm-20-e28]--[@b17-prm-20-e28]) to geriatrics ([@b18-prm-20-e28]--[@b20-prm-20-e28]). Cognitive, physical, psychosocial and spiritual benefits of AAT include increased attention, orientation and mobility, as well as improved communication and elevated mood ([@b21-prm-20-e28]).

Because surgery and various invasive procedures generate substantial pain, varying resources and staff trained in caring for pediatric patients make a pediatric surgery department a unique place to care for children in pain. Many recent studies were conducted regarding individual (ie, sex, age) differences in pain perception ([@b15-prm-20-e28]--[@b20-prm-20-e28]). To date, no specific studies have been conducted to investigate the benefit of AAT on pain perception in children or adults. We aimed to evaluate the effects of aquarium therapy (ie, watching fish in the aquarium) because of the relaxation effects observed in elderly patients and patients with Alzheimer's disease ([@b12-prm-20-e28],[@b20-prm-20-e28],[@b22-prm-20-e28]). Because of ethics rules and constraints, especially due to the use of an experimental-based pain protocol, we conducted a pilot study involving a cohort of healthy adult volunteers. The purpose of the present study was to determine the effect of fish aquarium AAT (FA-AAT) on volunteers' pain perception, as assessed using a novel testing device (the Pain Matcher; Cefar Medical AB, Sweden).

METHODS
=======

Population studied
------------------

Sixty-nine healthy subjects (40 women \[mean age 28.8 years\] and 29 men \[mean age 27.3 years\]) were recruited among students and trainees in pediatric orthopedics in the department of pediatric orthopedic surgery to participate in the present study. No participants had any skin disease, histamine-induced allergy, asthma, diabetes or pain. Patients had not consumed any medication that was intended for pain or that contained an antihistamine, and none were pregnant. After the experimental procedure was explained, all subjects provided consent before the study. The local Ethics Committee approved the study.

A control group comprised 12 healthy subjects (four men, eight women; mean age 27.4 years) randomly assigned from the cohort of 69 volunteers.

Aquarium installation
---------------------

A 265-gallon (approximately 1000 L) saltwater aquarium was used for the protocol ([Figure 1](#f1-prm-20-e28){ref-type="fig"}). The aquarium was located in the main waiting room of the Department of Pediatric Orthopedics at Armand Trousseau Hospital in Paris, France. The live population included \>20 different species of soft and hard corals, and \>25 fish including several species of surgeonfish. The aquarium lighting system consisted of three LED projectors, mimicking natural reef lighting at a water depth of 5 m.

Experimental pain protocol
--------------------------

Pain perception was assessed using an electrical stimulation device, the Pain Matcher ([@b23-prm-20-e28],[@b24-prm-20-e28]). The device provides constant current stimulation despite variable skin resistance. It is controlled by a microprocessor, which provides rectangular pulses at a frequency of 10 Hz and an amplitude of 10 mA. The stimulus intensity is increased by raising from zero to a possible maximum of 396 (in increments of four) over a total of 99 steps. The electrical charge per second is extremely low and causes no tissue damage. The intensity value (0 to 99) relates directly to the pulse width and is displayed on a liquid crystal display screen ([Figure 2](#f2-prm-20-e28){ref-type="fig"}). The subjects were instructed to grasp the electrodes of the Pain Matcher between the thumb and index finger of their right hand. The electrical stimulation was started by the subjects, who were told to press a button on the device at the first noticeable sensation (the sensation threshold). Subsequently, the device was restarted, and the subjects were instructed to press the button when the perceived signal became painful (the pain threshold). This method is highly reliable, well tolerated by patients, reported to be easy to use, and may be useful when evaluating pain perception in both patients and control subjects ([@b23-prm-20-e28],[@b24-prm-20-e28]).

Study procedure
---------------

Measurements were obtained for the 69 subjects to assess thresholds for sensation and pain. Measurements were assessed before aquarium exposure and repeated after 5 min, 10 min, 20 min and 30 min of continuous aquarium contemplation. The subjects were seated comfortably at a distance from 0.5 m to 1.5 m in front of the aquarium. They were invited to watch the marine fauna (ie, corals and fish) in a continuous manner. Other distractions (oral communication, cell-phones, etc) were not permitted during the aquarium-watching phases. The same measurements were repeated 10 min after aquarium exposure ended. As a control group, 12 healthy subjects (four men, eight women, mean age 27.4 years), randomly assigned from the cohort of 69 volunteers, were retested for the same thresholds while watching a white wall, without any distractions.

Statistical method
------------------

All data were collected in a computerized database and analyzed using SPSS version 16 (IBM Corporation, USA). The normality of quantitative variables was assessed before testing, using multivariate skewness and kurtosis tests. For data with normal distribution, statistical analysis was performed using paired and unpaired *t* tests. Statistical differences between sensation and pain thresholds were assessed according to sex and various lengths of aquarium exposure. In the control group, due to a non-normal distribution of data, nonparametric testing was performed using the Wilcoxon signed-rank test; P\<0.05 was considered to be statistically significant.

RESULTS
=======

[Table 1](#t1-prm-20-e28){ref-type="table"} presents median and range (minimum and maximum) values for the first noticeable sensation and the pain threshold Pain Matcher values in both the aquarium and control groups. The normality study showed a normal distribution for sensation values, but not for pain threshold values in the aquarium group. In the control group, the value distribution was not consistent with a normal distribution. Statistical analysis was conducted using a paired *t* test for sensation values and using a Wilcoxon signed-rank test for pain threshold values in the aquarium group and for all the data in the control group.

[Table 2](#t2-prm-20-e28){ref-type="table"} presents the results of the statistical analysis (paired analysis) comparing Pain Matcher values at different times during aquarium contemplation. No differences between sensation thresholds at different times of the procedure were observed. However, pain thresholds were significantly augmented after 5 min, 10 min, 20 min and 30 min of aquarium contemplation compared with initial threshold values before exposure, and they remained significantly higher 10 min after aquarium contemplation ceased compared with the initial measurement ([Figure 3](#f3-prm-20-e28){ref-type="fig"}). Statistical analysis revealed no significant difference between pain threshold measures after 30 min of aquarium exposure and 10 min after exposure ended (Wilcoxon test; Z=−1.591, P=0.112). These findings suggest a remnant effect of aquarium exposure on healthy subjects.

Control group data analysis showed no statistically significant differences in sensation and pain measurements at any time during the experiment ([Table 2](#t2-prm-20-e28){ref-type="table"}).

Despite statistical analysis revealing no differences regarding sensation thresholds according to the sex of subjects exposed to the aquarium, the difference between men and women was very significant regarding pain threshold values. Men had significant higher pain threshold values before aquarium exposure (P\<0.0001). After aquarium contemplation, pain thresholds were increased in both men and women. However, male pain thresholds remained significantly higher than female pain thresholds (P=0.001 to P\<0.0001) ([Table 3](#t3-prm-20-e28){ref-type="table"}).

DISCUSSION
==========

The relaxing effects of a fish aquarium reported in a literature review ([@b22-prm-20-e28],[@b25-prm-20-e28]) was the primary motivation for the original installation in a surgery department. Other studies have demonstrated cognitive stimulation in elderly individuals ([@b18-prm-20-e28],[@b22-prm-20-e28]) and a nutritional intake increase in individuals with Alzheimer's disease after the introduction of fish aquariums ([@b20-prm-20-e28]). Increased comfort levels before dental surgery in patients who have watched fish have suggested an effect on pain control ([@b25-prm-20-e28]). Our study demonstrated a statistically significant increase in pain perception threshold after 5 min of exposure to aquarium contemplation. This threshold increased again after 10 min, 20 min and 30 min of FA-AAT compared with baseline levels. A remnant effect was noted up to 10 min after exposure. This short post-viewing time period could be useful in clinical practice to perform certain painful procedures in children, such as those involving needles, under improved conditions immediately after aquarium exposure. In our department, FA-AAT is now used as a nonpharmacological antinociceptive technique combined with a protocol of inhalational oxygen/nitrous oxide mixtures for needle-related procedures. Children and parents are invited to watch the aquarium for 10 min to 20 min before venous punctures.

AAT has gained widespread support and application over the past few decades. During the past decade, it has become more widely accepted that pet ownership and animal assistance in therapy and education may have several positive effects on humans. Controlled studies have shown that petting a companion dog decreases blood pressure in healthy individuals and both decreases blood pressure and increases peripheral skin temperature in individuals with hypertension ([@b12-prm-20-e28]). In treating psychiatric disorders, AAT sessions involving a dog were compared with therapeutic recreation; patients with psychotic disorders, mood disorders and other diagnoses showed statistically reduced anxiety scores after the AAT session ([@b21-prm-20-e28]).

Recent years have witnessed substantially increased research investigating individual differences in pain perception. For example, the literature in this area clearly suggests that men and women differ in their responses to pain, with increased pain sensitivity and risk for clinical pain commonly observed in female subjects ([@b26-prm-20-e28],[@b27-prm-20-e28]). We also noted this difference in our study, in which pain thresholds were higher in men than in women. Recent studies have demonstrated that anxiety and sex may be influential in determining the relative efficacy of distraction-and emotion-based attentional strategies for pain management ([@b28-prm-20-e28]).

Nonpharmacological intervention is a critical component of total stress, anxiety and pain management protocols, and is used as an adjunct to pharmacological treatments ([@b1-prm-20-e28],[@b10-prm-20-e28]). One example is virtual reality, which has been used effectively to reduce preoperative anxiety and pain perception during pediatric dental treatment ([@b29-prm-20-e28]). Preschool children generally enjoy watching animated cartoons, and they can become sufficiently engrossed as to become oblivious to their surroundings and disregard verbal and tactile stimuli ([@b4-prm-20-e28],[@b5-prm-20-e28],[@b9-prm-20-e28]). Other forms of distraction have also been tested to reduce the pain and distress experienced by children while undergoing medical procedures. In a comparative study, Hartling et al ([@b3-prm-20-e28]) showed that music may have a positive impact on pain and distress for children during intravenous placement. Benefits were also observed for the parents and health care providers.

We fully recognize the potential for bias in the current study.

The present pilot study aimed to evaluate the distraction caused by marine fish on sensation and pain perception thresholds in healthy adults. Because of ethics rules and constraints, especially due to the use of electrical stimulation by the Pain Matcher, we did not perform this study on a cohort of preoperative children, but we suggest that the distraction effect should be the same, or perhaps higher, in children than in our cohort of healthy adult volunteers. Furthermore, because our study population knew the purpose of the research, it may have impacted the result. Because our study was based on the use of experimentally induced pain, we fully recognize the need to study a sample of children undergoing a needle procedure, for example, to extrapolate the effect of aquarium therapy on procedural pain in children. Such a study is planned for the near future.

Despite the fact that the results from our healthy adult population may not extrapolate to a pediatric population, we expect that aquarium distraction -- similar to animated cartoon distraction -- would have very beneficial effects on preoperative anxiety, especially among children three to seven years of age ([@b5-prm-20-e28]). We did not assess sensation and pain thresholds after \>30 min of aquarium exposure because the prolonged test length would bore subjects. Furthermore, we did not assess the remnant effect \>10 min after the end of aquarium exposure because we found that this time interval was sufficient to perform needle-related procedures, according to our nurses' protocols.

Other objective data, such as levels of anxiety, depression and hostility, could have been tested in our cohort, as in the study by Cole and Gawlinski ([@b12-prm-20-e28]). That study was conducted on 10 patients awaiting orthotopic heart transplantation at the University of California, Los Angeles Medical Center (Los Angeles, USA). A 15-gallon (56.7 L) saltwater fish tank containing multicoloured coral, foliage, stones and four colourful swimming fish of different shapes and sizes was installed in patients' rooms. Although the initiation of FA-AAT produced no difference in levels of anxiety, depression, hostility, dysphoria, positive affect or sensation-seeking in this group of patients, the project had other benefits. Patients expressed delight at having fish aquariums in their rooms, which humanized the environment. As in our department's experience, the aquarium provided cognitive stimulation and became a bridge for communication among patients, family and staff. For months, children and parents considered the fish in the aquarium as valued members of the care team. This program encouraged us to work with such alternative strategies and develop a pain management plan that will provide the greatest benefit. At our institution, children will benefit from both the latest medical approaches and proven, effective alternative therapies.
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![*Pictures of the marine aquarium used for subjects' distraction.* **A** *The 265-gallon (approximately 1000 L) saltwater aquarium was located in the department's main waiting room. Live population included \>20 species of soft and hard corals and \>25 fish with a specific lighting system that mimicked natural reef lighting at a depth of 5 m.* **B** *Children and parents are invited to watch the aquarium*](prm-20-e28-1){#f1-prm-20-e28}

![The Pain Matcher (Cefar Medical AB, Sweden) is an instrument for electrical stimulation that provides constant current stimulation despite variable skin resistance. The electrical charge per second is extremely low and causes no tissue damage. The intensity value (0 to 99) is directly related to the pulse width and is displayed on a liquid crystal screen](prm-20-e28-2){#f2-prm-20-e28}

![Graphic representation of cumulative values of sensation and pain threshold measurements at different times of the protocol](prm-20-e28-3){#f3-prm-20-e28}

###### 

Pain Matcher^[\*](#tfn1-prm-20-e28){ref-type="table-fn"}^ threshold values in both groups

                                     **Aquarium group**   **Control group**                            
  ---------------------------------- -------------------- ------------------- ------- ------- -------- -------
  First noticeable sensation         Before exposure      4.07                2--8    0       4.07     3--8
  5 min                              4.03                 2--7                5       3.86    3--5     
  10 min                             4.03                 2--9                10      4.07    3--5     
  20 min                             4.04                 2--7                20      4.07    3--5     
  30 min                             4.22                 2--8                30      3.93    2--7     
  10 min after the end of exposure   4.20                 2--10               40      4.21    3--5     
  Pain threshold                     Before exposure      16.03               3--63   0       18.43    8--68
  5 min                              19.67                3--82               5       17.57   10--34   
  10 min                             22.16                3--100              10      17.64   9--42    
  20 min                             21.88                3--100              20      21.79   11--86   
  30 min                             25.20                3--100              30      22.21   9--86    
  10 min after the end of exposure   24.58                4--100              40      23.71   10--99   

Cefar Medical AB, Sweden

###### 

Statistical analysis regarding Pain Matcher^[\*](#tfn2-prm-20-e28){ref-type="table-fn"}^ threshold values in both groups

                                                        **Aquarium group**         **Control group**                                               
  ----------------------------------------------------- -------------------------- ------------------- ----------------- ---------------- -------- -------
  First noticeable sensation                            Before exposure -- 5 min   0.455               0.651             0 min -- 5 min   −0.551   0.582
  Before exposure -- 10 min                             0.323                      0.747               0 min -- 10 min   −0.905           0.366    
  Before exposure -- 20 min                             0.234                      0.816               0 min -- 20 min   −0.367           0.713    
  Before exposure -- 30 min                             −0.971                     0.335               0 min -- 30 min   −0.155           0.877    
  Before exposure -- 10 min after the end of exposure   −0.809                     0.421               0 min -- 40 min   −0.734           0.463    
                                                                                   **Z**               **P**                              **Z**    **P**
                                                                                                                                                   
  Pain threshold (Wilcoxon signed ranks test)           Before exposure -- 5 min   −5.11               \< 0.0001         0 min -- 5 min   −1.268   0.205
  Before exposure -- 10 min                             −5.98                      \< 0.0001           0 min -- 10 min   −0.805           0.404    
  Before exposure -- 20 min                             −5.79                      \< 0.0001           0 min -- 20 min   −0.876           0.381    
  Before exposure -- 30 min                             −6.28                      \< 0.0001           0 min -- 30 min   −1.379           0.168    
  Before exposure -- 10 min after the end of exposure   −6.13                      \< 0.0001           0 min -- 40 min   −0.035           0.972    

Cefar Medical AB, Sweden

###### 

Pain Matcher^[\*](#tfn3-prm-20-e28){ref-type="table-fn"}^ threshold values in male (n=29) and female (n=40) subjects exposed to the aquarium

                                     **Delay**         **Sex**       **Mean ± SD**   ***t* test**   **P**
  ---------------------------------- ----------------- ------------- --------------- -------------- ----------
  First noticeable sensation         Before exposure   M             4.17±1.31       0.63           0.53
  F                                  4.00±0.96                                                      
  5 min                              M                 4.28±1.33     1.55            0.13           
  F                                  3.85±0.95                                                      
  10 min                             M                 4.24±1.50     1.20            0.24           
  F                                  3.88±1.04                                                      
  20 min                             M                 4.24±1.09     1.26            0.21           
  F                                  3.90±1.13                                                      
  30 min                             M                 4.38±1.18     0.90            0.37           
  F                                  4.10±1.34                                                      
  10 min after the end of exposure   M                 4.34±1.14     0.77            0.44           
  F                                  4.10±1.41                                                      
  Pain threshold                     Before exposure   M             22.28±13.29     4.61           \<0.0001
  F                                  11.50±5.60                                                     
  5 min                              M                 27.28±16.94   4.31            \<0.0001       
  F                                  14.15±7.85                                                     
  10 min                             M                 31.69±21.71   4.36            \<0.0001       
  F                                  15.25±8.48                                                     
  20 min                             M                 28.59±18.65   3.33            0.001          
  F                                  17.03±9.96                                                     
  30 min                             M                 34.83±22.96   4.03            \<0.0001       
  F                                  18.23±10.59                                                    
  10 min after the end of exposure   M                 34.48±26.11   3.62            0.001          
  F                                  17.40±12.36                                                    

Cefar Medical AB, Sweden. F Female; M Male
